The gene therapy field is not a place for a biotech that isn't willing to rub elbows with giants, and we have certainly seen regulatory activity ...
https://www.google.com/url?rct=j&sa=t&url=https://seekingalpha.com/article/4475972-beam-therapeutics-stock-selling-crispr-buying-opportunity&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEnT3nnZIPk_JLVkQTbWXjlInrdVA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.